LaCasce Discusses the Potential Impact of Drug Shortages on Clinical Trials
Ann LaCasce, MD, MMSc, discusses the effects that chemotherapy drug shortages may have on clinical trials and patient accrual.
Brentuximab Vedotin in Combination With Bendamustine for Patients With Hodgkin Lymphoma
Ann S. LaCasce, MD, discusses the combination of brentuximab vedotin and bendamustine for the treatment of patients with Hodgkin lymphoma.